Ishmael Kasvosve Selected Research

Iron

12/2021	Similar Ferroportin Q248H polymorphism prevalence in patients with Plasmodium falciparum malaria and control subjects in the low-endemic setting of Botswana.
3/2013	Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
2/2013	Effect of ferroportin polymorphism on iron homeostasis and infection.
9/2010	Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children.
1/2010	Haptoglobin polymorphism and infection.
9/2006	Association of serum transferrin receptor concentration with markers of inflammation in Zimbabwean children.
11/2005	Effect of ferroportin Q248H polymorphism on iron status in African children.
6/2005	Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ishmael Kasvosve Research Topics

Disease

7	Infections 01/2021 - 01/2010
6	Tuberculosis (Tuberculoses) 03/2020 - 01/2014
4	Malaria 12/2021 - 11/2005
3	Neoplasms (Cancer) 01/2022 - 01/2012
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2018
3	Iron Overload 02/2013 - 02/2002
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 03/2021
2	Coinfection 03/2021 - 01/2018
2	Disease Progression 01/2021 - 01/2018
2	Iron Deficiencies 09/2010 - 11/2005
2	Inflammation (Inflammations) 09/2006 - 11/2005
1	Cryptococcal Meningitis 06/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 02/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Dehydration (Water Stress) 01/2018
1	Enteritis 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017
1	HIV Infections (HIV Infection) 01/2016
1	Hyperferritinemia 04/2015
1	Pancreatitis 01/2014
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2013
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Noncommunicable Diseases 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Chronic Disease (Chronic Diseases) 09/2010
1	Anemia 09/2010
1	Virus Diseases (Viral Diseases) 01/2010
1	Hepatitis C 11/2008
1	Hemochromatosis (Bronze Diabetes) 06/2005

Drug/Important Bio-Agent (IBA)

8	IronIBA 12/2021 - 06/2005
7	metal transporting protein 1 (ferroportin)IBA 12/2021 - 11/2005
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 11/2005
4	AntigensIBA 01/2021 - 01/2013
4	Hemoglobins (Hemoglobin)IBA 01/2018 - 09/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
3	VaccinesIBA 02/2019 - 11/2017
3	HepcidinsIBA 04/2015 - 02/2013
3	Ferritins (Ferritin)IBA 03/2013 - 11/2005
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022 - 01/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2019 - 05/2018
2	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine FDA Link 01/2018 - 01/2018
2	Blood Group Antigens (Blood Groups)IBA 01/2016 - 01/2013
2	HaptoglobinsIBA 01/2012 - 01/2010
2	Dietary IronIBA 11/2008 - 02/2002
2	C-Reactive ProteinIBA 09/2006 - 11/2005
2	Transferrin Receptors (Transferrin Receptor)IBA 09/2006 - 11/2005
1	Cytochrome P-450 CYP3AIBA 01/2022
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2022
1	Cytochrome P-450 CYP2C8IBA 01/2022
1	Cytochrome P-450 CYP2C9IBA 01/2022
1	A-factor (Streptomyces)IBA 12/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2019
1	Immunoglobulins (Immunoglobulin)IBA 02/2019
1	Complement System Proteins (Complement)IBA 12/2018
1	ElectrolytesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Rotavirus VaccinesIBA 01/2018
1	ParaffinIBA 11/2017
1	Formaldehyde (Formol)FDA Link 11/2017
1	Phospholipases (Phospholipase)IBA 01/2014
1	Amylases FDA Link 01/2014
1	EnzymesIBA 01/2014
1	Lipase (Acid Lipase)FDA Link 01/2014
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Oxygen (Dioxygen)IBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2010
1	Blood Proteins (Serum Proteins)IBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 09/2006
1	Transferrin (beta 2 Transferrin)IBA 06/2005

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2018
1	Art Therapy 03/2020
1	Immunomodulation 01/2010